To include your compound in the COVID-19 Resource Center, submit it here.

PDL gains on ruling in antibody royalty case

PDL BioPharma Inc. (NASDAQ:PDLI) gained $0.56 (10%) to $6.31 on Monday after the Second Judicial District Court of Nevada denied motions

Read the full 212 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE